Advanced search
Publication Cover
Expert Opinion on Drug Metabolism & Toxicology Volume 1, 2005 - Issue 4
Submit an article Journal homepage
174
Views
27
CrossRef citations to date
0
Altmetric
Review

Computational models to predict aqueous drug solubility, permeability and intestinal absorption

Christel AS Bergström Uppsala University, Center of Pharmaceutical Informatics, Department of Pharmacy, Biomedical Centre, PO Box 580, SE-751 23 Uppsala, Sweden
Pages 613-627 | Published online: 30 Nov 2005

Bibliography

  • KENNEDY T: Managing the drug discovery /development interface. Drug Discov. Today (1997) 2:436–444.
  • CLARK DE, GROOTENHUIS PD: Progress in computational methods for the prediction of ADMET properties. Curr. Opin. Drug Discov. Devel. (2002) 5(3):382–390.
  • MODI S: Computational approaches to the understanding of ADMET properties and problems. Drug Discov. Today (2003) 8(14):621–623.
  • VAN DE WATERBEEMD H, GIFFORD E: ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. (2003) 2(3):192–204.
  • ARTURSSON P, KARLSSON J: Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. (1991) 175(3):880–885.
  • ARTURSSON P, BORCHARDT RT: Intestinal drug absorption and metabolism in cell culture: Caco-2 and beyond. Pharm. Res. (1997) 14(12):1655–1658.
  • LIPINSKI CA, LOMBARDO F, DOMINY BW, FEENY PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. (1997) 23:3–25.
  • KOLA I, LANDIS J: Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. (2004) 3(8):711–716.
  • CHIOU WL: The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. J. Pharmacokinet. Biopharm. (2001) 28(1):3–6.
  • PAN L, HO Q, TSUTSUI K, TAKAHASHI L: Comparison of chromatographic and spectroscopic methods used to rank compounds for aqueous solubility. J. Pharm. Sci. (2001) 90(4):521–529.
  • TAUB ME, KRISTENSEN L, FROKJAER S: Optimized conditions for MDCK permeability and turbidimetric solubility studies using compounds representative of BCS classes I - IV. Eur. J. Pharm. Sci. (2002) 15(4):331–340.
  • BERGSTRÖM CAS, NORINDER U, LUTHMAN K, ARTURSSON P: Experimental and computational screening models for prediction of aqueous drug solubility. Pharm. Res. (2002) 19(2):182–188.
  • GLOMME A, MÄRZ J, DRESSMAN J: Comparison of a miniaturized shake-flask solubility method with automated potentiometric acid/base titrations and calculated solubilities. J. Pharm. Sci. (2005) 94(1):1–16.
  • PIDGEON C, ONG S, LIU H et al. : IAM chromatography: an in vitro screen for predicting drug membrane permeability. J. Med. Chem. (1995) 38:590–594.
  • ONG S, LIU H, PIDGEON C: Immobilized-artificial-membrane chromatography: measurements of membrane partition coefficient and predicting drug membrane permeability. J. Chromatogr. A (1996) 728(1–2):113–128.
  • KANSY M, SENNER F, GUBERNATOR K: Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. J. Med. Chem. (1998) 41(7):1007–1010.
  • BERMEJO M, AVDEEF A, RUIZ A et al.: PAMPA-a drug absorption in vitro model 7. Comparing rat in situ, Caco-2, and PAMPA permeability of fluoroquinolones. Eur. J. Pharm. Sci. (2004) 21(4):429–441.
  • HIDALGO IJ, RAUB TJ, BORCHARDT RT: Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology (1989) 96(3):736–749.
  • ENGMAN HA, LENNERNÄS H, TAIPALENSUU J, OTTER C, LEIDVIK B, ARTURSSON P: CYP3A4, CYP3A5, and MDR1 in human small and large intestinal cell lines suitable for drug transport studies. J. Pharm. Sci. (2001) 90(11):1736–1751.
  • POLLI JW, WRING SA, HUMPHREYS JE et al. : Rational use of in vitro P-glycoprotein assays in drug discovery. J. Pharmacol. Exp. Ther. (2001) 299(2):620–628.
  • TAVELIN S, MILOVIC V, OCKLIND G, OLSSON S, ARTURSSON P: A conditionally immortilized epithelial cell line for studies of intestinal drug transport. J. Pharmacol. Exp. Ther. (1999) 290(3):1212–1221.
  • TAVELIN S, TAIPALENSUU J, SODERBERG L, MORRISON R, CHONG S, ARTURSSON P: Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers. Pharm. Res. (2003) 20(3):397–405.
  • IRVINE JD, TAKAHASHI L, LOCKHART K et al. : MDCK (Madin- Darby canine kidney) cells: a tool for membrane permeability screening. J. Pharm. Sci. (1999) 88(1):28–33.
  • LENNERNÄS H, AHRENSTEDT Ö, HÄLLGREN R, KNUTSON L, RYDE M, PAALZOW L: Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man. Pharm. Res. (1992) 9:1243–1251.
  • FAGERHOLM U, JOHANSSON M, LENNERNÄS H: Comparison between permeability coefficients in rats and human jejunum. Pharm. Res. (1996) 13:1336–1342.
  • LENNERNÄS H, NYLANDER S, UNGELL A-L: Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans. Pharm. Res. (1997) 14:667–671.
  • UNGELL AL, NYLANDER S, BERGSTRAND S, SJÖBERG A, LENNERNÄS H: Membrane transport of drugs in different regions of the intestinal tract of the rat. J. Pharm. Sci. (1998) 87(3):360–366.
  • KIER LB, HALL LH: Connectivity in structure-activity analysis. Research Studies Press, John Wiley and Sons, Letchworth, UK (1986).
  • KIER LB, HALL LH: An electrotopological-state index for atoms in molecules. Pharm. Res. (1990) 7(8):801–807.
  • MANNHOLD R, REKKER RF, SONNTAG C, TER LAAK AM, DROSS K, POLYMEROPOULOS EE: Comparative evaluation of the predictive power of calculation procedures for molecular lipophilicity. J. Pharm. Sci. (1995) 84(12):1410–1419.
  • ABRAHAM MH: Scales of solute hydrogen-bonding: their construction and application to physicochemical and biochemical processed. Chem. Soc. Rev. (1993) 22:73–83.
  • MANNHOLD R, VAN DE WATERBEEMD H: Substructure and whole molecule approaches for calculating logP. J. Comput. Aided. Mol. Des. (2001) 15(4):337–354.
  • RAEVSKY OA, SKVORTSOV VS: 3D hydrogen bond thermodynamics (HYBOT) potentials in molecular modelling. J. Comput. Aided. Mol. Des. (2002) 16(1):1–10.
  • PALM K, STENBERG P, LUTHMAN K, ARTURSSON P: Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. (1997) 14(5):568–571.
  • STENBERG P, LUTHMAN K, ARTURSSON P: Prediction of membrane permeability to peptides from calculated dynamic molecular surface properties. Pharm. Res. (1999) 16(2):205–212.
  • STENBERG P, NORINDER U, LUTHMAN K, ARTURSSON P: Experimental and computational screening models for the prediction of intestinal drug absorption. J. Med. Chem. (2001) 44(12):1927–1937.
  • VAN DE WATERBEEMD H, KANSY M: Hydrogen-bonding capacity and brain penetration. Chimia (1992) 46:299–303.
  • WINIWARTER S, BONHAM NM, AX F, HALLBERG A, LENNERNÄS H, KARLEN A: Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. (1998) 41(25):4939–4949.
  • ERTL P, ROHDE B, SELZER P: Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. (2000) 43(20):3714–3717.
  • CRUCIANI G, PASTOR M, GUBA W: VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur. J. Pharm. Sci. (2000) 11(Suppl. 2):S29–S39.
  • NORINDER U, OSTERBERG T, ARTURSSON P: Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics. Pharm. Res. (1997) 14(12):1786–1791.
  • NORINDER U, OSTERBERG T, ARTURSSON P: Theoretical calculation and prediction of intestinal absorption of drugs in humans using MolSurf parametrization and PLS statistics. Eur. J. Pharm. Sci. (1999) 8(1):49–56.
  • CLARK DE: Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood.brain barrier penetration. J. Pharm. Sci. (1999) 88(8):815–821.
  • CLARK DE: Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. (1999) 88(8):807–814.
  • MOTULSKY H: Intuitive biostatistics. Oxford University Press, Inc., New York, US (1995).
  • HOSKULDSSON A: PLS regression methods. J. Chemometr. (1988) 2:211–228.
  • OPREA TI, GOTTFRIES J: Toward minimalistic modeling of oral drug absorption. J. Mol. Graph. Model. (1999) 17(5–6):261–274.
  • ICHIKAWA H: Hierarchy neural networks as applied to pharmaceutical problems. Adv. Drug Deliv. Rev. (2003) 55(9):1119–1147.
  • WINKLER DA, BURDEN FR: Bayesian neural nets for modeling in drug discovery. Drug Discov. Today: Biosilico (2004) 2(3):104–111.
  • GOMBAR VK, POLLI JW, HUMPHREYS JE, WRING SA, SERABJIT-SINGH CS: Predicting Pglycoprotein substrates by a quantitative structure-activity relationship model. J. Pharm. Sci. (2004) 93(4):957–968.
  • BERGSTROM CAS, LUTHMAN K, ARTURSSON P: Accuracy of calculated pH-dependent aqueous drug solubility. Eur. J. Pharm. Sci. (2004) 22(5):387–398.
  • AJAY A, WALTERS WP, MURCKO MA: Can we learn to distinguish between ’edruglike’ and ’enondrug-like’ molecules? J. Med. Chem. (1998) 41(18):3314–3324.
  • FRIMURER TM, BYWATER R, NAERUM L, LAURITSEN LN, BRUNAK S: Improving the odds in discriminating ’edrug-like’ from ’enon druglike’ compounds. J. Chem. Inf. Comput. Sci. (2000) 40(6):1315–1324.
  • OPREA TI: Property distribution of drugrelated chemical databases. J. Comput. Aided. Mol. Des. (2000) 14(3):251–264.
  • OPREA TI, GOTTFRIES J: Chemography: the art of navigating in chemical space. J. Comb. Chem. (2001) 3(2):157–166.
  • WALTERS WP, MURCKO MA: Prediction of ’edrug-likeness’. Adv. Drug Deliv. Rev. (2002) 54(3):255–271.
  • PICKETT SD, MCLAY IM, CLARK DE: Enhancing the hit-to-lead properties of lead optimization libraries. J. Chem. Inf. Comput. Sci. (2000) 40(2):263–272.
  • HILDEBRAND J: Solubility. XII. Regular solutions. J. Am. Chem. Soc. (1929) 51:66–80.
  • SCATCHARD G: Equilibria in nonelectrolyte solutions in relation to the vapor pressures and densities of the components. Chem. Rev. (1931) 8:321–333.
  • HILDEBRAND JC, SCOTT RL: The solubility of nonelectrolytes. Reinhold Publishing Corporation, New York, US (1950).
  • KAMLET MJ, ABBOUD J-LM, ABRAHAM MH, TAFT RW: Linear solvation energy relationships. 23. A comprehensive collection of the solvatochrominc parameters, γ, α and α, and some methods for simplifying the generalized solvatochromic equation. J. Org. Chem. (1983) 48:2877–2887.
  • KAMLET MJ, DOHERTY RM, ABBOUD J-LM, ABRAHAM MH, TAFT RW: Linear solvation energy relationships: 36. Molecular properties governing solubilities of organic nonelectrolytes in water. J. Pharm. Sci. (1986) 75(4):338–349.
  • BUSTAMANTE P, MARTIN A, GONZALEZ-GUISANDEZ MA: Partial solubility parameters and solvatochromic parameters for predicting the solubility of single and multiple drugs in individual solvents. J. Pharm. Sci. (1993) 82(6):635–640.
  • BUSTAMANTE P, ESCALERA B, MARTIN A, SELLES E: A modification of the extended Hildebrand approach to predict the solubility of structurally related drugs in solvent mixtures. J. Pharm. Pharmacol. (1993) 43:253–257.
  • KAMLET MJ, DOHERTY RM, FISEROVA-BERGEROVA V, CARR PW, ABRAHAM MH, TAFT RW: Solubility properties in biological media 9. Prediction of solubility and partition of organic nonelectrolytes in blood and tissue from solvatochromic parameters. J. Pharm. Sci. (1987) 76(1):14–17.
  • ABRAHAM MH, LE J: The correlation and prediction of the solubility of compounds in water using an amended solvation energy relationship. J. Pharm. Sci. (1999) 88(9):868–880.
  • HANSCH C, QUINLAN JE, LAWRENCE GL: The linear free-energy relationship between partition coefficients and the aqueous solubility of organic liquids. J. Org. Chem. (1968) 33(1):347–350.
  • YALKOWSKY SH, VALVANI SC: Solubility and partitioning I: solubility of nonelectrolytes in water. J. Pharm. Sci. (1980) 69(8):912–922.
  • YALKOWSKY SH: Solubility and partitioning V: dependence of solubility on melting point. J. Pharm. Sci. (1981) 70(8):971–973.
  • YALKOWSKY SH, PINAL R, BANERJEE S: Water solubility: a critique of the solvatochromic approach. J. Pharm. Sci. (1988) 77(1):74–77.
  • YALKOWSKY SH, PINAL R: Estimation of the aqueous solubility of complex organic componds. Chemosphere (1993) 26(7):1239–1261.
  • LI A, YALKOWSKY SH: Solubility of organic solutes in ethanol/water mixtures. J. Pharm. Sci. (1994) 83(12):1735–1740.
  • MYRDAL PB, MANKA AM, YALKOWSKY SH: Aquafac 3: aqueous functional group activity coefficients; application to the estimation of aqueous solubility. Chemosphere (1995) 30(9):1619–1637.
  • RAN Y, YALKOWSKY SH: Prediction of drug solubility by the general solubility equation (GSE). J. Chem. Inf. Comput. Sci. (2001) 41(2):354–357.
  • BERGSTROM CAS, NORINDER U, LUTHMAN K, ARTURSSON P: Molecular descriptors influencing melting point and their role in classification of solid drugs. J. Chem. Inf. Comput. Sci. (2003) 43(4):1177–1185.
  • CLARK M: Generalized fragmentsubstructure- based property prediction method. J. Chem. Inf. Model. (2005) 45(1):30–38.
  • KARTHIKEYAN M, GLEN RC, BENDER A: General melting point prediction based on a diverse compound data set and artificial neural networks. J. Chem. Inf. Model. (2005) 45(3):581–590.
  • MEYLAN WM, HOWARD PH, BOETHLING RS: Improved method for estimating water solubility from octanol/ water partition coefficient. Environ. Toxicol. Chem. (1996) 15(2):100–106.
  • MCFARLAND JW, AVDEEF A, BERGER CM, RAEVSKY OA: Estimating the water solubilities of crystalline compounds from their chemical structures alone. J. Chem. Inf. Comput. Sci. (2001) 41:1355–1359.
  • RAEVSKY OA, TREPALIN SV, TREPALINA HP, GERASIMENKO VA, RAEVSKAJA OE: SLIPPER-2001 - software for predicting molecular properties on the basis of physicochemical descriptors and structural similarity. J. Chem. Inf. Comput. Sci. (2002) 42(3):540–549.
  • AMIDON GL, YALKOWSKY SH, LEUNG S: Solubility of nonelectrolytes in polar solvents II. Solubility of aliphatic alcohols in water. J. Pharm. Sci. (1974) 63(12):1866.
  • JORGENSEN WL, DUFFY EM: Prediction of drug solubility from structure. Adv. Drug Deliv. Rev. (2002) 54(3):355–366.
  • MITCHELL BE, JURS PC: Prediction of aqueous solubility of organic compounds from molecular structure. J. Chem. Inf. Comput. Sci. (1998) 38(3):489–496.
  • WANCHANA S, YAMASHITA F, HASHIDA M: Quantitative structure/ property relationship analysis on aqueous solubility using genetic algorithm-combined partial least squares method. Pharmazie (2002) 57(2):127–129.
  • CATANA C, GAO H, ORRENIUS C, STOUTEN PF: Linear and nonlinear methods in modeling the aqueous solubility of organic compounds. J. Chem. Inf. Model. (2005) 45(1):170–176.
  • BODOR N, HUANG M-J: A new method for the estimation of the aqueous solubility of organic compounds. J. Pharm. Sci. (1992) 81(9):954–960.
  • NELSON TM, JURS PC: Prediction of aqueous solubility of organic compounds. J. Chem. Inf. Comput. Sci. (1993) 34(3):601–609.
  • SUTTER JM, JURS PC: Prediction of aqueous solubility for a diverse set of heteroatom-containing organic compounds using a quantitative structure-property relationship. J. Chem. Inf. Comput. Sci. (1996) 36:100–107.
  • HUUSKONEN J, SALO M, TASKINEN J: Neural network modeling for estimation of the aqueous solubility of structurally related drugs. J. Pharm. Sci. (1997) 86(4):450–454.
  • HUUSKONEN J, SALO M, TASKINEN J: Aqueous solubility prediction of drugs based on molecular topology and neural network modeling. J. Chem. Inf. Comput. Sci. (1998) 38:450–456.
  • HUUSKONEN J, RANTANEN J, LIVINGSTONE D: Prediction of aqueous solubility for a diverse set of organic compounds based on atom-type electrotopological state indices. Eur. J. Med. Chem. (2000) 35(12):1081–1088.
  • HUUSKONEN J: Estimation of aqueous solubility for a diverse set of organic compounds based on molecular topology. J. Chem. Inf. Comput. Sci. (2000) 40(3):773–777.
  • HUUSKONEN J: Estimation of water solubility from atom-type electrotopological state indices. Environ. Toxicol. Chem. (2001) 20(3):491–497.
  • HUUSKONEN J: Estimation of aqueous solubility in drug design. Comb. Chem. High Throughput Screen. (2001) 4(3):311–316.
  • YAFFE D, COHEN Y, ESPINOSA G, ARENAS A, GIRALT F: A fuzzy ARTMAP based on quantitative structure-property relationships (QSPRs) for predicting aqueous solubility of organic compounds. J. Chem. Inf. Comput. Sci. (2001) 41(5):1177–1207.
  • TETKO IV, TANCHUK VY, KASHEVA TN, VILLA AE: Estimation of aqueous solubility of chemical compounds using E-state indices. J. Chem. Inf. Comput. Sci. (2001) 41(6):1488–1493.
  • ENGKVIST O, WREDE P: Highthroughput, in silico prediction of aqueous solubility based on one- and twodimensional descriptors. J. Chem. Inf. Comput. Sci. (2002) 42(5):1247–1249.
  • CHENG A, MERZ KM: Prediction of aqueous solubility of a diverse set of compounds using quantitative structure- property relationships. J. Med. Chem. (2003) 46:3572–3580.
  • VOTANO JR, PARHAM M, HALL LH, KIER LB: New predictors for several ADME/Tox properties: aqueous solubility, human oral absorption, and Ames genotoxicity using topological descriptors. Mol. Div. (2004) 8(4):379–391.
  • BERGSTRÖM CAS, STRAFFORD M, LAZOROVA L, AVDEEF A, LUTHMAN K, ARTURSSON P: Absorption classification of oral drugs based on molecular surface properties. J. Med. Chem. (2003) 46(4):558–570.
  • BERGSTRÖM CAS, WASSVIK CM, NORINDER U, LUTHMAN K, ARTURSSON P: Global and local computational models for prediction of aqueous solubility of drug-like molecules. J. Chem. Inf. Comput. Sci. (2004) 44(4):1477–1488.
  • CONRADI RA, HILGERS AR, HO NF, BURTON PS: The influence of peptide structure on transport across Caco-2 cells. Pharm. Res. (1991) 8(12):1453–1460.
  • CONRADI RA, HILGERS AR, HO NF, BURTON PS: The influence of peptide structure on transport across Caco-2 cells. II. Peptide bond modification which results in improved permeability. Pharm. Res. (1992) 9(3):435–439.
  • REN S, DAS A, LIEN EJ: QSAR analysis of membrane permeability to organic compounds. J. Drug Target. (1996) 4:103–107.
  • PALM K, LUTHMAN K, UNGELL AL et al. : Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J. Med. Chem. (1998) 41(27):5382–5392.
  • CAMENISCH G, ALSENZ J, VAN DE WATERBEEMD H, FOLKERS G: Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’ lipophilicity and molecular weight. Eur. J. Pharm. Sci. (1998) 6(4):317–324.
  • HJORTH KRARUP L, THOGER CHRISTENSEN I, HOVGAARD L, FROKJAER S: Predicting drug absorption from molecular surface properties based on molecular dynamics simulations. Pharm. Res. (1998) 15(7):972–978.
  • VAN DE WATERBEEMD H, CAMENISCH G, FOLKERS G, CHRETIEN JR, RAEVSKY OA: Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors. J. Drug Target. (1998) 6(2):151–165.
  • ÖSTERBERG T, NORINDER U: Prediction of drug transport processes using simple parameters and PLS statistics. The use of ACD/logP and ACD/ChemSketch descriptors. Eur. J. Pharm. Sci. (2001) 12(3):327–337.
  • YAMASHITA F, WANCHANA S, HASHIDA M: Quantitative structure/ property relationship analysis of Caco-2 permeability using a genetic algorithmbased partial least squares method. J. Pharm. Sci. (2002) 91(10):2230–2239.
  • MARRERO PONCE Y, CABRERA PEREZ MA, ROMERO ZALDIVAR V, GONZALEZ DIAZ H, TORRENS F: A new topological descriptors based model for predicting intestinal epithelial transport of drugs in Caco-2 cell culture. J. Pharm. Pharm. Sci. (2004) 7(2):186–199.
  • STENBERG P, LUTHMAN K, ELLENS H et al. : Prediction of the intestinal absorption of endothelin receptor antagonists using three theoretical methods of increasing complexity. Pharm. Res. (1999) 16(10):1520–1526.
  • ZHAO YH, LE J, ABRAHAM MH et al. : Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. (2001) 90(6):749–784.
  • AGATONOVIC-KUSTRIN S, BERESFORD R, YUSOF AP: Theoretically-derived molecular descriptors important in human intestinal absorption. J. Pharm. Biomed. Anal. (2001) 25(2):227–237.
  • KLOPMAN G, STEFAN LR, SAIAKHOV RD: ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. (2002) 17(4–5):253–263.
  • NIWA T: Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from twodimensional chemical structures. J. Chem. Inf. Comput. Sci. (2003) 43(1):113–119.
  • WOLOHAN PR, CLARK RD: Predicting drug pharmacokinetic properties using molecular interaction fields and SIMCA. J. Comput. Aided. Mol. Des. (2003) 17(1):65–76.
  • PEREZ MA, SANZ MB, TORRES LR, AVALOS RG, GONZALEZ MP, DIAZ HG: A topological sub-structural approach for predicting human intestinal absorption of drugs. Eur. J. Med. Chem. (2004) 39(11):905–916.
  • SUN H: A universal molecular descriptor system for prediction of logP, logS, logBB and absorption. J. Chem. Inf. Comput. Sci. (2004) 44(2):748–757.
  • XUE Y, LI ZR, YAP CW, SUN LZ, CHEN X, CHEN YZ: Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents. J. Chem. Inf. Comput. Sci. (2004) 44(5):1630–1638.
  • OBATA K, SUGANO K, SAITOH R et al. : Prediction of oral drug absorption in humans by theoretical passive absorption model. Int. J. Pharm. (2005) 293(1–2):183–192.
  • MATSSON P, BERGSTRÖM CAS, NAGAHARA N, TAVELIN S, NORINDER U, ARTURSSON P: Exploring the role of different drug transport routes in permeability screening. J. Med. Chem. (2005) 48(2):604–613.
  • CLARK RD, WOLOHAN PR: Molecular design and bioavailability. Curr. Top. Med. Chem. (2003) 3(11):1269–1288.
  • TURNER JV, MADDALENA DJ, AGATONOVIC-KUSTRIN S: Bioavailability prediction based on molecular structure for a diverse series of drugs. Pharm. Res. (2004) 21(1):68–82.
  • PARROTT N, LAVE T: Prediction of intestinal absorption: comparative assessment of GASTROPLUS and IDEA. Eur. J. Pharm. Sci. (2002) 17(1–2):51–61.
  • AMIDON GL, LENNERNÄS H, SHAH VP, CRISON JR: A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution an in vivo bioavailability. Pharm. Res. (1995) 12(3):413–420.
  • VARMA M, KHANDAVILLI S, ASHOKRAJ Y et al. : Biopharmaceutic classification system: a scientific framework for pharmacokinetic optimization in drug research. Curr. Drug Met. (2004) 5(5):375–388.
  • KASIM NA, WHITEHOUSE M, RAMACHANDRAN C et al. : Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol. Pharm. (2004) 1:85–96.
  • WU CY, BENET LZ: Predicting drug disposition via application of BCS: transport/absorption/elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm. Res. (2005) 22(1):11–23.
  • LIPINSKI CA: Drug-like properties and the causes of poor solubility and poor permeability. J. Pharmacol. Toxicol. Methods (2000) 44(1):235–249.

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.